"","Country.Name","Country.Code","GNI_per_c_WB","year_GNI","iso3c","Economy","Region","Income group","q_GNI_per_c_WB","continent","owid_vac_intro","owid_vac_F40","owid_vac_F70","who_vac_intro","min_vac_intro","diff_owid_who_intro","diff_min_vac_intro_8Dec2020","diff_intro_F40","diff_intro_F70","owid_who","diff_min_vac_intro_8Dec2020_clean","V1_date_group","V1_group","V40_date_group","V40_group","V1_dummy","V40_dummy","V70_dummy","V1_dummy_no_date","V40_dummy_no_date","V70_dummy_no_date","vaccines","last_observation_date","source_name","source_website","CIGB CIGB-66/Abdala","Cansino Ad5-nCoV","Biological E Corbevax","Bharat Covaxin/BBV152","Shifa Pharmed COVIran","Chumakov Center CoviVac","Vector Institute EpiVacCorona","Institute of Medical Biology CAMS vaccine","Janssen Ad26.COV2.S","Shenzhen Kangtai KCONVAC","Medicago CoVLP","Medigen MVC-COV1901","Moderna mRNA-1273","Novavax NVX-CoV2373","Oxford/AstraZeneca ChAdOx1-S","BioNTech/Pfizer BNT162b2","RIBSP Kazakhstan QazCovid-in","Beijing/Sinopharm BBIBP-CorV","Wuhan/Sinopharm vaccine","Sinovac CoronaVac","Instituto Finlay de Vacunas Soberana 02","Instituto Finlay de Vacunas Soberana 01","Gamaleya Gam-COVID-Vac/Sputnik V","Erciyes TURKOVAC","AZLB ZF2001","Sanofi/GSK CoV2 preS dTM","Valneva VLA2001","mRNA","Vectored","Inactivated","Protein"
"1","Aruba","ABW",40570,2019,"ABW","Aruba","Latin America & Caribbean","High income",4,"North America",2021-03-29,"2021-05-22","2021-09-27",2021-02-17,2021-02-17,40,71,94,222,"who",71,"feb/2021","60-89","before Jun/2021","<180","yes","yes","yes","yes","yes","yes","Pfizer/BioNTech",2023-10-13,"Government of Aruba","https://www.government.aw",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0
"2","Afghanistan","AFG",2200,2019,"AFG","Afghanistan","South Asia","Low income",1,"Asia",2021-02-28,"2023-06-20",NA,2021-02-22,2021-02-22,6,76,848,NA,"who",76,"feb/2021","60-89","Dec/2021 +","360+","yes","no","no","yes","yes","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-10-08,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"3","Angola","AGO",6260,2019,"AGO","Angola","Sub-Saharan Africa","Lower middle income",2,"Africa",2021-03-08,NA,NA,2021-03-10,2021-03-08,-2,90,NA,NA,"owid",90,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca",2023-09-17,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"4","Albania","ALB",14220,2019,"ALB","Albania","Europe & Central Asia","Upper middle income",2,"Europe",2021-01-13,"2022-02-01",NA,2021-01-13,2021-01-13,0,36,384,NA,"equal",36,"jan/2021","30-59","Dec/2021 +","360+","yes","no","no","yes","yes","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V",2023-07-16,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,1,0,0,0,0,1,1,1,0
"5","United Arab Emirates","ARE",75180,2019,"ARE","United Arab Emirates","Middle East & North Africa","High income",4,"Asia",2021-01-05,"2021-04-20","2021-07-15",NA,2021-01-05,NA,28,105,191,"owid",28,"jan/2021","<30","before Jun/2021","<180","yes","yes","yes","yes","yes","yes","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2022-06-20,"National Emergency Crisis and Disaster Management Authority","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"6","Argentina","ARG",22100,2019,"ARG","Argentina","Latin America & Caribbean","Upper middle income",3,"South America",2020-12-29,"2021-09-18","2022-01-14",2020-12-29,2020-12-29,0,21,263,381,"equal",21,"before jan/2021","<30","Sep-Nov/2021","180-269","yes","yes","yes","yes","yes","yes","CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2023-10-17,"Ministry of Health","https://covidstats.com.ar/",0,1,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"7","Armenia","ARM",15120,2019,"ARM","Armenia","Europe & Central Asia","Upper middle income",3,"Asia",2021-03-31,NA,NA,2021-01-27,2021-01-27,63,50,NA,NA,"who",50,"jan/2021","30-59","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, Sputnik Light, Sputnik V",2023-09-03,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,1,1,1,0,0,1,0,0,0,0,1,1,1,0
"8","Antigua and Barbuda","ATG",22500,2019,"ATG","Antigua and Barbuda","Latin America & Caribbean","High income",3,"North America",2021-03-15,"2021-09-24",NA,2021-03-01,2021-03-01,14,83,207,NA,"who",83,"march/2021 +","60-89","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2022-09-16,"Ministry of Health","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"9","Australia","AUS",50180,2019,"AUS","Australia","East Asia & Pacific","High income",4,"Oceania",2021-02-22,"2021-09-24","2021-11-21",2021-02-21,2021-02-21,1,75,215,273,"who",75,"feb/2021","60-89","Sep-Nov/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-03-24,"Government of Australia via CovidBaseAU","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"10","Austria","AUT",59540,2019,"AUT","Austria","Europe & Central Asia","High income",4,"Europe",2021-01-08,"2021-07-09","2021-12-24",2020-12-30,2020-12-30,9,22,191,359,"who",22,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK, Valneva",2023-06-30,"European CDC","https://www.ecdc.europa.eu/en/publications-data/data-covid-19-vaccination-eu-eea",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,1,1,1,1,1,1
"11","Azerbaijan","AZE",14470,2019,"AZE","Azerbaijan","Europe & Central Asia","Upper middle income",2,"Asia",2021-02-06,"2021-10-14",NA,2021-01-20,2021-01-20,17,43,267,NA,"who",43,"jan/2021","30-59","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V",2022-08-28,"Government of Azerbaijan","https://koronavirusinfo.az",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,1,0,0,0,0,1,1,1,0
"12","Burundi","BDI",760,2019,"BDI","Burundi","Sub-Saharan Africa","Low income",1,"Africa",2021-11-09,NA,NA,2021-10-18,2021-10-18,22,314,NA,NA,"who",314,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Sinopharm/Beijing",2023-08-27,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"13","Belgium","BEL",56280,2019,"BEL","Belgium","Europe & Central Asia","High income",4,"Europe",2020-12-30,"2021-07-08","2021-08-30",2020-12-30,2020-12-30,0,22,190,243,"equal",22,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-09-24,"Sciensano","https://epistat.wiv-isp.be/covid/",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"14","Benin","BEN",3260,2019,"BEN","Benin","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-05-12,NA,NA,2021-03-29,2021-03-29,44,111,NA,NA,"who",111,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac",2022-12-18,"Ministry of Health","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0
"15","Burkina Faso","BFA",2080,2019,"BFA","Burkina Faso","Sub-Saharan Africa","Low income",1,"Africa",2021-06-10,NA,NA,2021-06-02,2021-06-02,8,176,NA,NA,"who",176,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing",2023-07-23,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"16","Bangladesh","BGD",5930,2019,"BGD","Bangladesh","South Asia","Lower middle income",2,"Asia",2021-02-07,"2022-02-18","2022-07-16",2021-01-27,2021-01-27,11,50,387,535,"who",50,"jan/2021","30-59","Dec/2021 +","360+","yes","no","no","yes","yes","yes","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac",2023-10-18,"Directorate General of Health Services","http://103.247.238.92/webportal/pages/covid19-vaccination-update.php",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0
"17","Bulgaria","BGR",24460,2019,"BGR","Bulgaria","Europe & Central Asia","Upper middle income",3,"Europe",2020-12-29,NA,NA,2020-12-30,2020-12-29,-1,21,NA,NA,"owid",21,"before jan/2021","<30","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-10-18,"Ministry of Health","https://coronavirus.bg/bg/statistika",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"18","Bahrain","BHR",48830,2019,"BHR","Bahrain","Middle East & North Africa","High income",4,"Asia",2020-12-23,"2021-05-11","2021-07-17",2020-11-04,2020-11-04,49,-34,188,255,"who",0,"before jan/2021","<30","before Jun/2021","180-269","yes","yes","yes","yes","yes","yes","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2022-12-21,"Ministry of Health","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"19","Bahamas, The","BHS",34970,2019,"BHS","Bahamas, The","Latin America & Caribbean","High income",4,"North America",2021-03-14,"2022-09-16",NA,2021-03-14,2021-03-14,0,96,551,NA,"equal",96,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech",2023-05-12,"Pan American Health Organization","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"20","Bosnia and Herzegovina","BIH",15870,2019,"BIH","Bosnia and Herzegovina","Europe & Central Asia","Upper middle income",3,"Europe",2021-04-14,NA,NA,NA,2021-04-14,NA,127,NA,NA,"owid",127,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V",2022-01-29,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,1,0,0,0,0,1,1,1,0
"21","Belarus","BLR",19510,2019,"BLR","Belarus","Europe & Central Asia","Upper middle income",3,"Europe",2021-02-18,"2022-01-16",NA,2021-02-03,2021-02-03,15,57,347,NA,"who",57,"feb/2021","30-59","Dec/2021 +","270-359","yes","no","no","yes","yes","no","KoviVac/Chumakov, Sinopharm/Beijing, Sputnik Light, Sputnik V",2023-08-13,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,1,0
"22","Belize","BLZ",8770,2019,"BLZ","Belize","Latin America & Caribbean","Upper middle income",2,"North America",2021-03-02,"2021-11-12",NA,2021-03-01,2021-03-01,1,83,256,NA,"who",83,"march/2021 +","60-89","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2023-05-12,"World Health Organization","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"23","Bermuda","BMU",86290,2019,"BMU","Bermuda","North America","High income",4,"North America",2021-01-16,"2021-05-12","2021-12-10",2021-01-11,2021-01-11,5,34,121,333,"who",34,"jan/2021","30-59","before Jun/2021","<180","yes","yes","yes","yes","yes","yes","Oxford/AstraZeneca, Pfizer/BioNTech",2022-07-08,"Pan American Health Organization","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"24","Bolivia","BOL",8710,2019,"BOL","Bolivia","Latin America & Caribbean","Lower middle income",2,"South America",2021-02-02,"2022-01-14",NA,2021-01-30,2021-01-30,3,53,349,NA,"who",53,"jan/2021","30-59","Dec/2021 +","270-359","yes","no","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2022-10-07,"Ministry of Health via https://www.boligrafica.com/","https://github.com/dquintani/vacunacion/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"25","Brazil","BRA",14890,2019,"BRA","Brazil","Latin America & Caribbean","Upper middle income",3,"South America",2021-01-19,"2021-09-24","2022-02-05",2021-01-17,2021-01-17,2,40,250,384,"who",40,"jan/2021","30-59","Sep-Nov/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac",2023-03-22,"State governments via coronavirusbra1.github.io","https://coronavirusbra1.github.io",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0
"26","Barbados","BRB",15790,2019,"BRB","Barbados","Latin America & Caribbean","High income",3,"North America",2021-02-15,"2021-10-11",NA,2021-01-08,2021-01-08,38,31,276,NA,"who",31,"jan/2021","30-59","Sep-Nov/2021","270-359","yes","yes","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2023-06-02,"Ministry of Health","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"27","Brunei Darussalam","BRN",65730,2019,"BRN","Brunei Darussalam","East Asia & Pacific","High income",4,"Asia",2021-04-03,"2021-09-28","2021-11-19",2021-04-03,2021-04-03,0,116,178,230,"equal",116,"march/2021 +","90+","Sep-Nov/2021","<180","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2023-06-30,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"28","Bhutan","BTN",11180,2019,"BTN","Bhutan","South Asia","Lower middle income",2,"Asia",2021-03-27,"2021-07-23","2021-10-31",2021-03-27,2021-03-27,0,109,118,218,"equal",109,"march/2021 +","90+","Jun-Aug/2021","<180","yes","yes","yes","yes","yes","yes","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2022-10-30,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"29","Botswana","BWA",14930,2019,"BWA","Botswana","Sub-Saharan Africa","Upper middle income",3,"Africa",2021-04-02,"2022-01-17",NA,2021-03-26,2021-03-26,7,108,297,NA,"who",108,"march/2021 +","90+","Dec/2021 +","270-359","yes","no","no","yes","yes","no","Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac",2023-05-07,"Africa Centres for Disease Control and Prevention","https://covid19.who.int/",0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0
"30","Central African Republic","CAF",960,2019,"CAF","Central African Republic","Sub-Saharan Africa","Low income",1,"Africa",2021-05-12,"2023-03-05",NA,2021-03-19,2021-03-19,54,101,716,NA,"who",101,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","no","Covaxin, Oxford/AstraZeneca",2023-09-03,"Africa Centres for Disease Control and Prevention","https://covid19.who.int/",0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0
"31","Canada","CAN",49140,2019,"CAN","Canada","North America","High income",4,"North America",2020-12-16,"2021-07-09","2021-09-28",2020-12-14,2020-12-14,2,6,207,288,"who",6,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Medicago, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-02-02,"Official data from provinces via covid19tracker.ca","https://covid19tracker.ca/vaccinationtracker.html",0,0,0,0,0,0,0,0,1,0,1,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"32","Switzerland","CHE",71070,2019,"CHE","Switzerland","Europe & Central Asia","High income",4,"Europe",2020-12-24,NA,NA,2020-12-23,2020-12-23,1,15,NA,NA,"who",15,"before jan/2021","<30","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Moderna, Novavax, Pfizer/BioNTech",2023-07-03,"Federal Office of Public Health","https://opendata.swiss/en/dataset/covid-19-schweiz?detGeo=CH",0,0,0,0,0,0,0,0,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"33","Chile","CHL",24650,2019,"CHL","Chile","Latin America & Caribbean","High income",3,"South America",2020-12-25,"2021-05-25","2021-09-02",2020-12-21,2020-12-21,4,13,155,255,"who",13,"before jan/2021","<30","before Jun/2021","<180","yes","yes","yes","yes","yes","yes","CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac",2023-02-08,"Ministry of Health, via Ministry of Science GitHub repository","https://github.com/MinCiencia/Datos-COVID19",0,1,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0
"34","China","CHN",16610,2019,"CHN","China","East Asia & Pacific","Upper middle income",3,"Asia",2020-12-15,"2021-08-12","2021-09-15",2020-07-22,2020-07-22,146,-139,386,420,"who",0,"before jan/2021","<30","Jun-Aug/2021","360+","yes","yes","yes","yes","yes","yes","CanSino, IMBCAMS, KCONVAC, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, ZF2001",2023-02-09,"National Health Commission","https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202302/t20230211_263697.html",0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,1,1
"35","Cote d'Ivoire","CIV",5200,2019,"CIV","Côte d’Ivoire","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-03-06,"2022-12-18",NA,2021-03-01,2021-03-01,5,83,657,NA,"who",83,"march/2021 +","60-89","Dec/2021 +","360+","yes","no","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2023-02-19,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"36","Cameroon","CMR",3830,2019,"CMR","Cameroon","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-04-29,NA,NA,2021-04-12,2021-04-12,17,125,NA,NA,"who",125,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2023-09-17,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"37","Congo, Dem. Rep.","COD",1040,2019,"COD","Congo, Dem. Rep.","Sub-Saharan Africa","Low income",1,"Africa",2021-05-12,NA,NA,2021-04-19,2021-04-19,23,132,NA,NA,"who",132,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca",2023-06-04,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"38","Congo, Rep.","COG",3430,2019,"COG","Congo, Rep.","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-04-14,NA,NA,2021-03-23,2021-03-23,22,105,NA,NA,"who",105,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V",2022-07-31,"Africa Centres for Disease Control and Prevention","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"39","Colombia","COL",15530,2019,"COL","Colombia","Latin America & Caribbean","Upper middle income",3,"South America",2021-02-18,"2021-10-26","2022-07-29",2021-02-17,2021-02-17,1,71,251,527,"who",71,"feb/2021","60-89","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","yes","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac",2023-04-07,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0
"40","Comoros","COM",3450,2019,"COM","Comoros","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-04-21,"2022-07-03",NA,2021-04-10,2021-04-10,11,123,449,NA,"who",123,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","no","Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing",2022-10-02,"World Health Organization","https://covid19.who.int/",0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"41","Cabo Verde","CPV",6970,2019,"CPV","Cabo Verde","Sub-Saharan Africa","Lower middle income",2,"Africa",2021-03-24,"2021-11-26",NA,2021-03-18,2021-03-18,6,100,253,NA,"who",100,"march/2021 +","90+","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","no","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2022-09-25,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"42","Costa Rica","CRI",21260,2019,"CRI","Costa Rica","Latin America & Caribbean","Upper middle income",3,"North America",2021-01-03,"2021-09-27","2022-01-17",2020-12-24,2020-12-24,10,16,277,389,"who",16,"before jan/2021","<30","Sep-Nov/2021","270-359","yes","yes","yes","yes","yes","yes","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-06-02,"Costa Rican Social Security Fund","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"43","Curacao","CUW",25750,2019,"CUW","Curaçao","Latin America & Caribbean","High income",3,"North America",2021-03-29,"2021-06-21",NA,NA,2021-03-29,NA,111,84,NA,"owid",111,"march/2021 +","90+","Jun-Aug/2021","<180","yes","yes","no","yes","yes","no","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-05-12,"Government of Curacao","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"44","Cayman Islands","CYM",55930,2019,"CYM","Cayman Islands","Latin America & Caribbean","High income",4,"North America",2021-02-04,"2021-04-20","2021-08-06",2021-01-15,2021-01-15,20,38,95,203,"who",38,"jan/2021","30-59","before Jun/2021","<180","yes","yes","yes","yes","yes","yes","Oxford/AstraZeneca, Pfizer/BioNTech",2023-04-21,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"45","Cyprus","CYP",41660,2019,"CYP","Cyprus","Europe & Central Asia","High income",4,"Europe",2021-01-06,"2021-07-02","2022-01-31",2020-12-23,2020-12-23,14,15,191,404,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-02-22,"Ministry of Health","https://www.moh.gov.cy/moh/moh.nsf/All/0EFA027144C9E54AC22586BE0032B2F5",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"46","Czechia","CZE",41530,2019,"CZE","Czechia","Europe & Central Asia","High income",4,"Europe",2020-12-27,"2021-07-16",NA,2020-12-23,2020-12-23,4,15,205,NA,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac",2023-09-16,"Ministry of Health","https://onemocneni-aktualne.mzcr.cz/covid-19",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,1
"47","Germany","DEU",59260,2019,"DEU","Germany","Europe & Central Asia","High income",4,"Europe",2020-12-27,"2021-07-06","2021-12-18",2020-12-23,2020-12-23,4,15,195,360,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Valneva",2023-04-07,"Robert Koch Institut","https://impfdashboard.de/",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1
"48","Djibouti","DJI",4820,2019,"DJI","Djibouti","Middle East & North Africa","Lower middle income",1,"Africa",2021-04-17,NA,NA,2021-03-15,2021-03-15,33,97,NA,NA,"who",97,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-10-08,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"49","Dominica","DMA",12720,2019,"DMA","Dominica","Latin America & Caribbean","Upper middle income",2,"North America",2021-02-23,"2022-02-02",NA,2021-02-12,2021-02-12,11,66,355,NA,"who",66,"feb/2021","60-89","Dec/2021 +","270-359","yes","no","no","yes","yes","no","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2022-10-07,"Pan American Health Organization","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"50","Denmark","DNK",61830,2019,"DNK","Denmark","Europe & Central Asia","High income",4,"Europe",2021-01-01,"2021-07-16","2021-09-03",2020-12-16,2020-12-16,16,8,212,261,"who",8,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-09-01,"Statens Serum Institute","https://www.ecdc.europa.eu/en/publications-data/data-covid-19-vaccination-eu-eea",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"51","Dominican Republic","DOM",18070,2019,"DOM","Dominican Republic","Latin America & Caribbean","Upper middle income",3,"North America",2021-02-17,"2021-08-18",NA,2021-02-16,2021-02-16,1,70,183,NA,"who",70,"feb/2021","60-89","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac",2023-09-03,"Ministry of Public Health","https://vacunate.gob.do",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0
"52","Algeria","DZA",11820,2019,"DZA","Algeria","Middle East & North Africa","Lower middle income",2,"Africa",2021-02-19,NA,NA,2021-01-30,2021-01-30,20,53,NA,NA,"who",53,"jan/2021","30-59","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V",2022-09-04,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,1,0,0,0,0,0,1,1,0
"53","Ecuador","ECU",11520,2019,"ECU","Ecuador","Latin America & Caribbean","Upper middle income",2,"South America",2021-01-21,"2021-08-23","2021-12-28",2021-01-20,2021-01-20,1,43,215,342,"who",43,"jan/2021","30-59","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac",2023-03-31,"Government of Ecuador via Ecuacovid","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0
"54","Egypt, Arab Rep.","EGY",11230,2019,"EGY","Egypt, Arab Rep.","Middle East & North Africa","Lower middle income",2,"Africa",2021-03-27,NA,NA,2021-01-24,2021-01-24,62,47,NA,NA,"who",47,"jan/2021","30-59","not reached","not reached","yes","no","no","yes","no","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-05-21,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"55","Eritrea","ERI",1610,2011,"ERI","Eritrea","Sub-Saharan Africa","Low income",1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no date",NA,"not reached","not reached","not reached","not reached","no","no","no","no","no","no",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"56","Spain","ESP",43160,2019,"ESP","Spain","Europe & Central Asia","High income",4,"Europe",2021-01-04,"2021-07-04","2021-08-31",2020-12-30,2020-12-30,5,22,186,244,"who",22,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-05-24,"Ministry of Health","https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Informe_Comunicacion_20230526.ods",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"57","Estonia","EST",38230,2019,"EST","Estonia","Europe & Central Asia","High income",4,"Europe",2020-12-27,"2021-07-19",NA,2020-12-23,2020-12-23,4,15,208,NA,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-10-12,"National Health Board","https://opendata.digilugu.ee",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"58","Ethiopia","ETH",2260,2019,"ETH","Ethiopia","Sub-Saharan Africa","Low income",1,"Africa",2021-04-08,NA,NA,2021-03-13,2021-03-13,26,95,NA,NA,"who",95,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Covaxin, Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac",2023-05-28,"World Health Organization","https://covid19.who.int/",0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,0,0,1,1,0
"59","Finland","FIN",52070,2019,"FIN","Finland","Europe & Central Asia","High income",4,"Europe",2021-01-17,"2021-08-15","2021-10-31",2020-12-23,2020-12-23,25,15,235,312,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-08-22,"Finnish Institute for Health and Welfare","https://sampo.thl.fi/pivot/prod/en/vaccreg/cov19cov/fact_cov19cov",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"60","Fiji","FJI",12670,2019,"FJI","Fiji","East Asia & Pacific","Upper middle income",2,"Oceania",2021-04-13,"2021-09-21",NA,2021-03-07,2021-03-07,37,89,198,NA,"who",89,"march/2021 +","60-89","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","no","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-05-01,"SPC Public Health Division","https://stats.pacificdata.org/vis?tm=covid&pg=0&df[ds]=SPC2&df[id]=DF_COVID_VACCINATION&df[ag]=SPC&df[vs]=1.0",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"61","France","FRA",51580,2019,"FRA","France","Europe & Central Asia","High income",4,"Europe",2021-01-01,"2021-07-15","2021-12-03",2020-12-23,2020-12-23,9,15,204,345,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK",2023-07-10,"Public Health France","https://www.data.gouv.fr/fr/datasets/donnees-relatives-aux-personnes-vaccinees-contre-la-covid-19-1/",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1
"62","Gabon","GAB",13870,2019,"GAB","Gabon","Sub-Saharan Africa","Upper middle income",2,"Africa",2021-03-31,NA,NA,2021-03-23,2021-03-23,8,105,NA,NA,"who",105,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2023-02-05,"Africa Centres for Disease Control and Prevention","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"63","United Kingdom","GBR",49370,2019,"GBR","United Kingdom","Europe & Central Asia","High income",4,"Europe",2021-01-10,"2021-06-04","2021-12-23",2020-12-21,2020-12-21,20,13,165,367,"who",13,"before jan/2021","<30","Jun-Aug/2021","<180","yes","yes","yes","yes","yes","yes","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2022-09-11,"Government of the United Kingdom","https://coronavirus.data.gov.uk/details/vaccinations",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"64","Georgia","GEO",14930,2019,"GEO","Georgia","Europe & Central Asia","Upper middle income",3,"Asia",2021-03-29,NA,NA,2021-03-17,2021-03-17,12,99,NA,NA,"who",99,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac",2022-10-13,"National Center for Disease Control and Public Health","https://vaccines.ncdc.ge/vaccinationprocess/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0
"65","Ghana","GHA",5340,2019,"GHA","Ghana","Sub-Saharan Africa","Lower middle income",2,"Africa",2021-03-08,NA,NA,2021-03-02,2021-03-02,6,84,NA,NA,"who",84,"march/2021 +","60-89","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca, Sputnik V",2023-07-02,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0
"66","Guinea","GIN",2520,2019,"GIN","Guinea","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-03-31,"2023-09-24",NA,2021-03-05,2021-03-05,26,87,933,NA,"who",87,"march/2021 +","60-89","Dec/2021 +","360+","yes","no","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V",2023-04-02,"National Health Security Agency","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"67","Gambia, The","GMB",2140,2019,"GMB","Gambia, The","Sub-Saharan Africa","Low income",1,"Africa",2021-03-28,NA,NA,2021-03-10,2021-03-10,18,92,NA,NA,"who",92,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing",2023-03-19,"Africa Centres for Disease Control and Prevention","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"68","Guinea-Bissau","GNB",2010,2019,"GNB","Guinea-Bissau","Sub-Saharan Africa","Low income",1,"Africa",2021-05-12,NA,NA,2021-04-02,2021-04-02,40,115,NA,NA,"who",115,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca, Sinopharm/Beijing",2023-06-04,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"69","Equatorial Guinea","GNQ",12410,2019,"GNQ","Equatorial Guinea","Sub-Saharan Africa","Upper middle income",2,"Africa",2021-03-16,NA,NA,2021-02-12,2021-02-12,32,66,NA,NA,"who",66,"feb/2021","60-89","not reached","not reached","yes","no","no","yes","no","no","Sinopharm/Beijing, Sinovac",2022-07-24,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0
"70","Greece","GRC",30860,2019,"GRC","Greece","Europe & Central Asia","High income",3,"Europe",2020-12-29,"2021-07-09","2022-01-24",2020-12-23,2020-12-23,6,15,198,397,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-10-17,"Ministry of Health","https://www.data.gov.gr/datasets/mdg_emvolio/",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"71","Grenada","GRD",14510,2019,"GRD","Grenada","Latin America & Caribbean","Upper middle income",3,"North America",2021-02-16,NA,NA,2021-02-15,2021-02-15,1,69,NA,NA,"who",69,"feb/2021","60-89","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-03-17,"World Health Organization","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"72","Guatemala","GTM",8870,2019,"GTM","Guatemala","Latin America & Caribbean","Upper middle income",2,"North America",2021-02-27,NA,NA,2021-02-25,2021-02-25,2,79,NA,NA,"who",79,"feb/2021","60-89","not reached","not reached","yes","no","no","yes","no","no","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V",2023-05-12,"Ministry of Health","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0
"73","Guyana","GUY",13240,2019,"GUY","Guyana","Latin America & Caribbean","High income",2,"South America",2021-02-15,"2022-02-19",NA,2021-02-11,2021-02-11,4,65,373,NA,"who",65,"feb/2021","60-89","Dec/2021 +","360+","yes","no","no","yes","yes","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2023-02-17,"Ministry of Health","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"74","Hong Kong SAR, China","HKG",65240,2019,"HKG","Hong Kong SAR, China","East Asia & Pacific","High income",4,"Asia",2021-02-23,"2021-08-19","2022-03-04",NA,2021-02-23,NA,77,177,374,"owid",77,"feb/2021","60-89","Jun-Aug/2021","<180","yes","yes","yes","yes","yes","yes","Pfizer/BioNTech, Sinovac",2023-08-31,"Food and Health Bureau","https://data.gov.hk/en-data/dataset/hk-fhb-fhbcovid19-vaccination-rates-over-time-by-age",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0
"75","Honduras","HND",5390,2019,"HND","Honduras","Latin America & Caribbean","Lower middle income",2,"North America",2021-02-28,"2021-12-29",NA,2021-02-22,2021-02-22,6,76,310,NA,"who",76,"feb/2021","60-89","Dec/2021 +","270-359","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V",2023-06-02,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0
"76","Croatia","HRV",31610,2019,"HRV","Croatia","Europe & Central Asia","High income",3,"Europe",2020-12-30,"2021-09-01",NA,2020-12-23,2020-12-23,7,15,252,NA,"who",15,"before jan/2021","<30","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-10-10,"Ministry of Health","https://www.koronavirus.hr",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"77","Haiti","HTI",3240,2019,"HTI","Haiti","Latin America & Caribbean","Lower middle income",1,"North America",2021-07-21,NA,NA,NA,2021-07-21,NA,225,NA,NA,"owid",225,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Moderna",2023-06-02,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"78","Hungary","HUN",33630,2019,"HUN","Hungary","Europe & Central Asia","High income",4,"Europe",2020-12-28,"2021-06-05",NA,2020-12-23,2020-12-23,5,15,164,NA,"who",15,"before jan/2021","<30","Jun-Aug/2021","<180","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2022-12-27,"Government of Hungary","https://koronavirus.gov.hu//cikkek/6-millio-421-ezer-beoltott-4-397-az-uj-fertozott-es-elhunyt-56-beteg",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"79","Indonesia","IDN",11980,2019,"IDN","Indonesia","East Asia & Pacific","Upper middle income",2,"Asia",2021-01-22,"2021-12-25",NA,2021-01-13,2021-01-13,9,36,346,NA,"who",36,"jan/2021","30-59","Dec/2021 +","270-359","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac",2023-06-06,"Government of Indonesia","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,1,0,1,0,0,0,0,0,0,0,1,1,1,1
"80","India","IND",6820,2019,"IND","India","South Asia","Lower middle income",2,"Asia",2021-01-16,"2021-12-24",NA,2021-01-16,2021-01-16,0,39,342,NA,"equal",39,"jan/2021","30-59","Dec/2021 +","270-359","yes","yes","no","yes","yes","no","Corbevax, Covaxin, Novavax, Oxford/AstraZeneca, Sputnik V",2023-10-18,"Government of India","https://dashboard.cowin.gov.in/",0,0,1,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,1
"81","Ireland","IRL",69600,2019,"IRL","Ireland","Europe & Central Asia","High income",4,"Europe",2020-12-28,"2021-07-04","2021-09-06",2020-12-30,2020-12-28,-2,20,188,252,"owid",20,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-08-28,"Heath Service Executive","https://covid19ireland-geohive.hub.arcgis.com/",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"82","Iran, Islamic Rep.","IRN",14710,2019,"IRN","Iran, Islamic Rep.","Middle East & North Africa","Lower middle income",3,"Asia",2021-02-17,"2021-11-02",NA,2021-02-09,2021-02-09,8,63,266,NA,"who",63,"feb/2021","60-89","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","no","COVIran Barekat, CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Soberana02, Sputnik Light, Sputnik V",2023-08-15,"World Health Organization","https://covid19.who.int/",0,1,0,1,1,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,1,0,1,0,0,0,0,1,1,1,1
"83","Iraq","IRQ",10680,2019,"IRQ","Iraq","Middle East & North Africa","Upper middle income",2,"Asia",2021-03-29,NA,NA,2021-03-02,2021-03-02,27,84,NA,NA,"who",84,"march/2021 +","60-89","not reached","not reached","yes","no","no","yes","no","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-01-02,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"84","Iceland","ISL",59540,2019,"ISL","Iceland","Europe & Central Asia","High income",4,"Europe",2020-12-30,"2021-06-17","2021-08-25",2020-12-30,2020-12-30,0,22,169,238,"equal",22,"before jan/2021","<30","Jun-Aug/2021","<180","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2022-03-29,"Directorate of Health","https://www.covid.is/tolulegar-upplysingar-boluefni",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"85","Israel","ISR",40250,2019,"ISR","Israel","Middle East & North Africa","High income",4,"Asia",2020-12-20,"2021-03-07",NA,2020-12-16,2020-12-16,4,8,81,NA,"who",8,"before jan/2021","<30","before Jun/2021","<180","yes","yes","no","yes","yes","no","Moderna, Pfizer/BioNTech",2023-05-04,"Government of Israel","https://datadashboard.health.gov.il/COVID-19/general",0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0
"86","Italy","ITA",46190,2019,"ITA","Italy","Europe & Central Asia","High income",4,"Europe",2020-12-27,"2021-07-12","2021-10-04",2020-12-23,2020-12-23,4,15,201,285,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK",2023-10-17,"Extraordinary commissioner for the Covid-19 emergency","https://raw.githubusercontent.com/italia/covid19-opendata-vaccini/master/dati/somministrazioni-vaccini-latest.csv",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1
"87","Jamaica","JAM",10380,2019,"JAM","Jamaica","Latin America & Caribbean","Upper middle income",2,"North America",2021-03-14,NA,NA,2021-03-10,2021-03-10,4,92,NA,NA,"who",92,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-10-03,"Ministry of Health","https://vaccination.moh.gov.jm",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"88","Jordan","JOR",9960,2019,"JOR","Jordan","Middle East & North Africa","Lower middle income",2,"Asia",2021-01-23,"2022-06-27",NA,2021-01-13,2021-01-13,10,36,530,NA,"who",36,"jan/2021","30-59","Dec/2021 +","360+","yes","no","no","yes","yes","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2022-08-21,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"89","Japan","JPN",43970,2019,"JPN","Japan","East Asia & Pacific","High income",4,"Asia",2021-02-22,"2021-08-11","2021-10-16",2021-02-17,2021-02-17,5,71,175,241,"who",71,"feb/2021","60-89","Jun-Aug/2021","<180","yes","yes","yes","yes","yes","yes","Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-05-07,"Prime Minister's Office","https://www.kantei.go.jp/jp/headline/kansensho/vaccine.html",0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"90","Kazakhstan","KAZ",24030,2019,"KAZ","Kazakhstan","Europe & Central Asia","Upper middle income",3,"Asia",2021-02-11,"2021-11-12",NA,2021-04-07,2021-02-11,-55,65,274,NA,"owid",65,"feb/2021","60-89","Sep-Nov/2021","270-359","yes","yes","no","yes","yes","no","QazVac, Sinopharm/Beijing, Sputnik V",2023-01-17,"Government of Kazakhstan","https://www.coronavirus2020.kz/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,1,1,0
"91","Kenya","KEN",4720,2019,"KEN","Kenya","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-03-10,NA,NA,2021-03-05,2021-03-05,5,87,NA,NA,"who",87,"march/2021 +","60-89","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2023-04-02,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"92","Kyrgyz Republic","KGZ",5000,2019,"KGZ","Kyrgyz Republic","Europe & Central Asia","Lower middle income",1,"Asia",2021-04-06,NA,NA,2021-03-31,2021-03-31,6,113,NA,NA,"who",113,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Sinopharm/Beijing, Sputnik V",2023-09-08,"Ministry of Health","https://vc.emed.gov.kg/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,1,0
"93","Cambodia","KHM",4380,2019,"KHM","Cambodia","East Asia & Pacific","Lower middle income",1,"Asia",2021-02-12,"2021-08-12","2021-10-12",2021-02-10,2021-02-10,2,64,183,244,"who",64,"feb/2021","60-89","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac",2023-09-07,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0
"94","Kiribati","KIR",4350,2019,"KIR","Kiribati","East Asia & Pacific","Lower middle income",1,"Oceania",2021-08-09,"2022-03-21",NA,2021-05-26,2021-05-26,75,169,299,NA,"who",169,"march/2021 +","90+","Dec/2021 +","270-359","yes","no","no","yes","yes","no","Oxford/AstraZeneca",2023-02-20,"SPC Public Health Division","https://stats.pacificdata.org/vis?tm=covid&pg=0&df[ds]=SPC2&df[id]=DF_COVID_VACCINATION&df[ag]=SPC&df[vs]=1.0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"95","St. Kitts and Nevis","KNA",31850,2019,"KNA","St. Kitts and Nevis","Latin America & Caribbean","High income",3,"North America",2021-03-16,"2021-07-13",NA,2021-02-22,2021-02-22,22,76,141,NA,"who",76,"feb/2021","60-89","Jun-Aug/2021","<180","yes","yes","no","yes","yes","no","Oxford/AstraZeneca, Pfizer/BioNTech",2022-12-07,"Pan American Health Organization","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"96","Korea, Rep.","KOR",43780,2019,"KOR","Korea, Rep.","East Asia & Pacific","High income",4,"Asia",2021-02-26,"2021-09-15","2021-10-25",2021-02-26,2021-02-26,0,80,201,241,"equal",80,"feb/2021","60-89","Sep-Nov/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-05-26,"Korea Centers for Disease Control and Prevention","https://ncv.kdca.go.kr/",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"97","Kuwait","KWT",55930,2019,"KWT","Kuwait","Middle East & North Africa","High income",4,"Asia",2020-12-28,"2021-11-30","2021-11-30",2020-12-28,2020-12-28,0,20,337,337,"equal",20,"before jan/2021","<30","Sep-Nov/2021","270-359","yes","yes","yes","yes","yes","yes","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-10-08,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"98","Lao PDR","LAO",7700,2019,"LAO","Lao PDR","East Asia & Pacific","Lower middle income",2,"Asia",2021-03-17,"2021-11-23",NA,2020-11-25,2020-11-25,112,-13,363,NA,"who",0,"before jan/2021","<30","Sep-Nov/2021","360+","yes","yes","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2022-08-11,"World Health Organization","https://www.covid19.gov.la/index.php",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"99","Lebanon","LBN",17420,2019,"LBN","Lebanon","Middle East & North Africa","Lower middle income",3,"Asia",2021-02-15,"2022-03-24",NA,2021-02-14,2021-02-14,1,68,403,NA,"who",68,"feb/2021","60-89","Dec/2021 +","360+","yes","no","no","yes","yes","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2022-12-22,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"100","Liberia","LBR",1360,2019,"LBR","Liberia","Sub-Saharan Africa","Low income",1,"Africa",2021-05-12,"2022-06-26","2022-12-11",2021-04-01,2021-04-01,41,114,451,619,"who",114,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","yes","Oxford/AstraZeneca",2022-12-11,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"101","Libya","LBY",23750,2019,"LBY","Libya","Middle East & North Africa","Upper middle income",3,"Africa",2021-04-17,NA,NA,2021-04-11,2021-04-11,6,124,NA,NA,"who",124,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-01-16,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"102","St. Lucia","LCA",15160,2019,"LCA","St. Lucia","Latin America & Caribbean","Upper middle income",3,"North America",2021-03-04,NA,NA,2021-02-17,2021-02-17,15,71,NA,NA,"who",71,"feb/2021","60-89","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2022-12-02,"Ministry of Health","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"103","Sri Lanka","LKA",13820,2019,"LKA","Sri Lanka","South Asia","Lower middle income",2,"Asia",2021-01-29,"2021-09-03",NA,2021-01-29,2021-01-29,0,52,217,NA,"equal",52,"jan/2021","30-59","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","no","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2022-10-30,"Ministry of Health's Epidemiology Unit","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"104","Lesotho","LSO",2990,2019,"LSO","Lesotho","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-04-17,"2022-11-20",NA,2021-03-10,2021-03-10,38,92,620,NA,"who",92,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing",2023-03-19,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"105","Lithuania","LTU",38520,2019,"LTU","Lithuania","Europe & Central Asia","High income",4,"Europe",2020-12-27,"2021-07-06",NA,2020-12-23,2020-12-23,4,15,195,NA,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-10-18,"Ministry of Health","https://experience.arcgis.com/experience/cab84dcfe0464c2a8050a78f817924ca/page/page_3/",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"106","Luxembourg","LUX",79560,2019,"LUX","Luxembourg","Europe & Central Asia","High income",4,"Europe",2020-12-28,"2023-06-11","2023-06-11",2020-12-30,2020-12-28,-2,20,895,895,"owid",20,"before jan/2021","<30","Dec/2021 +","360+","yes","no","no","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-06-11,"Government of Luxembourg","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"107","Latvia","LVA",32400,2019,"LVA","Latvia","Europe & Central Asia","High income",3,"Europe",2020-12-28,"2021-08-24","2022-02-16",2020-12-30,2020-12-28,-2,20,239,415,"owid",20,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2022-07-11,"National Health Service","https://data.gov.lv/dati/eng/dataset/covid19-vakcinacijas",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"108","Macao SAR, China","MAC",113540,2019,"MAC","Macao SAR, China","East Asia & Pacific","High income",4,"Asia",2021-02-09,"2021-09-06","2022-02-21",NA,2021-02-09,NA,63,209,377,"owid",63,"feb/2021","60-89","Sep-Nov/2021","180-269","yes","yes","yes","yes","yes","yes","Pfizer/BioNTech, Sinopharm/Beijing",2023-04-13,"Government of Macao","https://www.ssm.gov.mo/apps1/COVID19Case/en.aspx",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0
"109","Morocco","MAR",8440,2019,"MAR","Morocco","Middle East & North Africa","Lower middle income",2,"Africa",2021-01-30,"2021-08-31",NA,2021-01-28,2021-01-28,2,51,215,NA,"who",51,"jan/2021","30-59","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-05-14,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"110","Moldova","MDA",14290,2019,"MDA","Moldova","Europe & Central Asia","Upper middle income",2,"Europe",2021-03-05,NA,NA,2021-03-03,2021-03-03,2,85,NA,NA,"who",85,"march/2021 +","60-89","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V",2023-08-27,"Ministry of Health","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"111","Madagascar","MDG",1590,2019,"MDG","Madagascar","Sub-Saharan Africa","Low income",1,"Africa",2021-05-18,NA,NA,2021-05-10,2021-05-10,8,153,NA,NA,"who",153,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing",2023-07-30,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"112","Maldives","MDV",19300,2019,"MDV","Maldives","South Asia","Upper middle income",3,"Asia",2021-02-02,"2021-07-07","2021-12-22",2021-02-01,2021-02-01,1,55,156,324,"who",55,"feb/2021","30-59","Jun-Aug/2021","<180","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V",2023-05-25,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"113","Mexico","MEX",19630,2019,"MEX","Mexico","Latin America & Caribbean","Upper middle income",3,"North America",2020-12-27,"2021-10-18",NA,2020-12-24,2020-12-24,3,16,298,NA,"who",16,"before jan/2021","<30","Sep-Nov/2021","270-359","yes","yes","no","yes","yes","no","CanSino, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V",2022-11-18,"World Health Organization","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,1,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,1,0,0,1,0,0,0,0,1,1,1,0
"114","North Macedonia","MKD",17180,2019,"MKD","North Macedonia","Europe & Central Asia","Upper middle income",3,"Europe",2021-03-16,"2022-06-19",NA,2021-02-17,2021-02-17,27,71,487,NA,"who",71,"feb/2021","60-89","Dec/2021 +","360+","yes","no","no","yes","yes","no","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, Sputnik V",2023-05-07,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,1,1,0,0,1,0,0,0,0,1,1,1,0
"115","Mali","MLI",2220,2019,"MLI","Mali","Sub-Saharan Africa","Low income",1,"Africa",2021-04-12,NA,NA,2021-03-31,2021-03-31,12,113,NA,NA,"who",113,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca",2023-05-14,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"116","Malta","MLT",45150,2019,"MLT","Malta","Middle East & North Africa","High income",4,"Europe",2021-01-17,"2021-06-01","2021-07-27",2020-12-23,2020-12-23,25,15,160,216,"who",15,"before jan/2021","<30","Jun-Aug/2021","<180","yes","yes","yes","yes","yes","yes","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-10-17,"COVID-19 Malta Public Health Response Team","https://github.com/COVID19-Malta/COVID19-Cases",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"117","Myanmar","MMR",4860,2019,"MMR","Myanmar","East Asia & Pacific","Lower middle income",1,"Asia",2021-01-27,"2022-03-22",NA,2021-01-27,2021-01-27,0,50,419,NA,"equal",50,"jan/2021","30-59","Dec/2021 +","360+","yes","no","no","yes","yes","no","Oxford/AstraZeneca, Sinopharm/Beijing",2023-05-02,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"118","Montenegro","MNE",24060,2019,"MNE","Montenegro","Europe & Central Asia","Upper middle income",3,"Europe",2021-02-25,"2021-11-20",NA,2021-02-24,2021-02-24,1,78,269,NA,"who",78,"feb/2021","60-89","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2022-08-26,"Government of Montenegro","https://www.covidodgovor.me/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"119","Mongolia","MNG",11550,2019,"MNG","Mongolia","East Asia & Pacific","Lower middle income",2,"Asia",2021-02-25,"2021-06-02",NA,2021-02-23,2021-02-23,2,77,99,NA,"who",77,"feb/2021","60-89","Jun-Aug/2021","<180","yes","yes","no","yes","yes","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2022-05-18,"Ministry of Health via ikon.mn","https://ikon.mn/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"120","Mozambique","MOZ",1320,2019,"MOZ","Mozambique","Sub-Saharan Africa","Low income",1,"Africa",2021-03-13,"2022-10-16",NA,2021-03-08,2021-03-08,5,90,587,NA,"who",90,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing",2023-07-02,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"121","Mauritania","MRT",5670,2019,"MRT","Mauritania","Sub-Saharan Africa","Lower middle income",2,"Africa",2021-04-01,NA,NA,2021-03-26,2021-03-26,6,108,NA,NA,"who",108,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca, Sinopharm/Beijing",2023-08-20,"Africa Centres for Disease Control and Prevention","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"122","Mauritius","MUS",25260,2019,"MUS","Mauritius","Sub-Saharan Africa","Upper middle income",3,"Africa",2021-02-01,"2021-07-26","2021-12-28",2021-01-26,2021-01-26,6,49,181,336,"who",49,"jan/2021","30-59","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing",2023-07-30,"World Health Organization","https://covid19.who.int/",0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"123","Malawi","MWI",1560,2019,"MWI","Malawi","Sub-Saharan Africa","Low income",1,"Africa",2021-03-17,NA,NA,2021-03-11,2021-03-11,6,93,NA,NA,"who",93,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Oxford/AstraZeneca",2023-07-02,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"124","Malaysia","MYS",28090,2019,"MYS","Malaysia","East Asia & Pacific","Upper middle income",3,"Asia",2021-02-26,"2021-08-24","2021-10-21",2021-02-24,2021-02-24,2,78,181,239,"who",78,"feb/2021","60-89","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac",2023-10-18,"Government of Malaysia","https://github.com/MoH-Malaysia/covid19-public",0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0
"125","Namibia","NAM",10180,2019,"NAM","Namibia","Sub-Saharan Africa","Upper middle income",2,"Africa",2021-03-25,NA,NA,2021-03-19,2021-03-19,6,101,NA,NA,"who",101,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2023-09-10,"Africa Centres for Disease Control and Prevention","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"126","Niger","NER",1320,2019,"NER","Niger","Sub-Saharan Africa","Low income",1,"Africa",2021-04-17,NA,NA,2021-03-29,2021-03-29,19,111,NA,NA,"who",111,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca, Sinopharm/Beijing",2023-07-30,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"127","Nigeria","NGA",5120,2019,"NGA","Nigeria","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-03-24,NA,NA,2021-03-05,2021-03-05,19,87,NA,NA,"who",87,"march/2021 +","60-89","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca",2023-09-17,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"128","Nicaragua","NIC",5370,2019,"NIC","Nicaragua","Latin America & Caribbean","Lower middle income",2,"North America",2021-04-14,"2021-12-29","2022-06-03",2021-03-03,2021-03-03,42,85,301,457,"who",85,"march/2021 +","60-89","Dec/2021 +","270-359","yes","yes","yes","yes","yes","yes","Abdala, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Soberana02, Sputnik Light, Sputnik V",2023-06-02,"World Health Organization","https://covid19.who.int/",1,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,0,1,0,1,0,0,0,0,1,1,1,1
"129","Netherlands","NLD",60460,2019,"NLD","Netherlands","Europe & Central Asia","High income",4,"Europe",2021-01-08,"2021-07-16",NA,2020-12-30,2020-12-30,9,22,198,NA,"who",22,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-09-01,"European CDC, via Marino van Zelst","https://www.ecdc.europa.eu/en/publications-data/data-covid-19-vaccination-eu-eea",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"130","Norway","NOR",71400,2019,"NOR","Norway","Europe & Central Asia","High income",4,"Europe",2020-12-28,"2021-08-12","2021-11-18",2020-12-23,2020-12-23,5,15,232,330,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Moderna, Pfizer/BioNTech",2022-11-13,"Norwegian Institute of Public Health","https://github.com/folkehelseinstituttet/surveillance_data",0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0
"131","Nepal","NPL",4130,2019,"NPL","Nepal","South Asia","Lower middle income",1,"Asia",2021-02-01,"2022-01-24","2022-08-29",2021-01-27,2021-01-27,5,50,362,579,"who",50,"jan/2021","30-59","Dec/2021 +","360+","yes","no","no","yes","yes","yes","Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2023-06-20,"World Health Organization","https://covid19.who.int/",0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"132","Nauru","NRU",17960,2019,"NRU","Nauru","East Asia & Pacific","High income",3,"Oceania",2021-04-09,"2021-07-20","2023-02-20",2021-04-09,2021-04-09,0,122,102,682,"equal",122,"march/2021 +","90+","Jun-Aug/2021","<180","yes","yes","no","yes","yes","yes","Oxford/AstraZeneca",2023-02-20,"World Health Organization","https://stats.pacificdata.org/vis?tm=covid&pg=0&df[ds]=SPC2&df[id]=DF_COVID_VACCINATION&df[ag]=SPC&df[vs]=1.0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"133","New Zealand","NZL",44790,2019,"NZL","New Zealand","East Asia & Pacific","High income",4,"Oceania",2021-02-22,"2021-10-05","2021-12-01",2021-02-19,2021-02-19,3,73,228,285,"who",73,"feb/2021","60-89","Sep-Nov/2021","180-269","yes","yes","yes","yes","yes","yes","Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-04-04,"Ministry of Health","https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-data-and-statistics/covid-19-vaccine-data",0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"134","Oman","OMN",32880,2019,"OMN","Oman","Middle East & North Africa","High income",4,"Asia",2020-12-28,"2021-09-28",NA,2020-12-29,2020-12-28,-1,20,274,NA,"owid",20,"before jan/2021","<30","Sep-Nov/2021","270-359","yes","yes","no","yes","yes","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2022-10-25,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"135","Pakistan","PAK",5280,2019,"PAK","Pakistan","South Asia","Lower middle income",2,"Asia",2021-02-10,"2022-02-16",NA,2021-02-03,2021-02-03,7,57,378,NA,"who",57,"feb/2021","30-59","Dec/2021 +","360+","yes","no","no","yes","yes","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-09-26,"National Command and Operation Centre","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"136","Panama","PAN",30750,2019,"PAN","Panama","Latin America & Caribbean","High income",3,"North America",2021-01-20,"2021-09-05","2022-05-13",2021-01-20,2021-01-20,0,43,228,478,"equal",43,"jan/2021","30-59","Sep-Nov/2021","180-269","yes","yes","yes","yes","yes","yes","Oxford/AstraZeneca, Pfizer/BioNTech",2023-05-12,"Pan American Health Organization","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"137","Peru","PER",12790,2019,"PER","Peru","Latin America & Caribbean","Upper middle income",2,"South America",2021-02-09,"2021-10-10","2022-02-15",2021-02-09,2021-02-09,0,63,243,371,"equal",63,"feb/2021","60-89","Sep-Nov/2021","180-269","yes","yes","yes","yes","yes","yes","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2023-10-12,"Ministerio de Salud via github.com/jmcastagnetto/covid-19-peru-vacunas","https://www.datosabiertos.gob.pe/dataset/vacunacion",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"138","Philippines","PHL",10010,2019,"PHL","Philippines","East Asia & Pacific","Lower middle income",2,"Asia",2021-03-04,"2021-12-26",NA,2021-03-01,2021-03-01,3,83,300,NA,"who",83,"march/2021 +","60-89","Dec/2021 +","270-359","yes","yes","no","yes","yes","no","Covaxin, Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-03-19,"Department of Health via ABS-CBN Investigative and Research Group","https://covid19.who.int/",0,0,0,1,0,0,0,0,1,0,0,0,1,1,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,1
"139","Palau","PLW",19520,2019,"PLW","Palau","East Asia & Pacific","Upper middle income",3,NA,NA,NA,NA,2021-01-03,2021-01-03,NA,26,NA,NA,"who",26,"jan/2021","<30","not reached","not reached","yes","no","no","yes","no","no",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"140","Papua New Guinea","PNG",3940,2019,"PNG","Papua New Guinea","East Asia & Pacific","Lower middle income",1,"Oceania",2021-04-20,NA,NA,2021-03-30,2021-03-30,21,112,NA,NA,"who",112,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca",2023-05-01,"SPC Public Health Division","https://stats.pacificdata.org/vis?tm=covid&pg=0&df[ds]=SPC2&df[id]=DF_COVID_VACCINATION&df[ag]=SPC&df[vs]=1.0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"141","Poland","POL",33510,2019,"POL","Poland","Europe & Central Asia","High income",4,"Europe",2020-12-28,"2021-07-17",NA,2020-12-23,2020-12-23,5,15,206,NA,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-10-17,"Ministry of Health","https://www.gov.pl/web/szczepimysie/raport-szczepien-przeciwko-covid-19",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"142","Portugal","PRT",36330,2019,"PRT","Portugal","Europe & Central Asia","High income",4,"Europe",2021-01-01,"2021-07-09","2021-08-27",2020-12-23,2020-12-23,9,15,198,247,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Covaxin, Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK, Sinopharm/Beijing, Sinovac",2023-09-01,"World Health Organization","https://www.ecdc.europa.eu/en/publications-data/data-covid-19-vaccination-eu-eea",0,0,0,1,0,0,0,0,1,0,0,0,1,1,1,1,0,1,0,1,0,0,0,0,0,1,0,1,1,1,1
"143","Paraguay","PRY",13770,2019,"PRY","Paraguay","Latin America & Caribbean","Upper middle income",2,"South America",2021-02-23,"2021-12-10",NA,2021-02-22,2021-02-22,1,76,291,NA,"who",76,"feb/2021","60-89","Dec/2021 +","270-359","yes","yes","no","yes","yes","no","Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V",2023-05-12,"Pan American Health Organization","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"144","West Bank and Gaza","PSE",7660,2019,"PSE","West Bank and Gaza","Middle East & North Africa","Upper middle income",2,"Asia",2021-03-30,NA,NA,2021-02-02,2021-02-02,56,56,NA,NA,"who",56,"feb/2021","30-59","not reached","not reached","yes","no","no","yes","no","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2022-10-18,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"145","Qatar","QAT",92300,2019,"QAT","Qatar","Middle East & North Africa","High income",4,"Asia",2021-01-28,"2021-05-31","2021-08-16",NA,2021-01-28,NA,51,123,200,"owid",51,"jan/2021","30-59","before Jun/2021","<180","yes","yes","yes","yes","yes","yes","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-05-07,"Ministry of Public Health","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"146","Romania","ROU",32600,2019,"ROU","Romania","Europe & Central Asia","High income",3,"Europe",2020-12-28,"2022-01-07",NA,2021-01-27,2020-12-28,-30,20,375,NA,"owid",20,"before jan/2021","<30","Dec/2021 +","360+","yes","no","no","yes","yes","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-08-27,"Government of Romania via datelazi.ro","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"147","Russian Federation","RUS",29120,2019,"RUS","Russian Federation","Europe & Central Asia","Upper middle income",3,"Europe",2020-12-15,"2021-12-04",NA,NA,2020-12-15,NA,7,354,NA,"owid",7,"before jan/2021","<30","Dec/2021 +","270-359","yes","yes","no","yes","yes","no","EpiVacCorona, Sputnik V",2023-09-27,"Official data from local governments via gogov.ru","https://gogov.ru/articles/covid-v-stats",0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,1
"148","Rwanda","RWA",2210,2019,"RWA","Rwanda","Sub-Saharan Africa","Low income",1,"Africa",2021-03-05,"2022-01-27","2023-01-01",2021-03-05,2021-03-05,0,87,328,667,"equal",87,"march/2021 +","60-89","Dec/2021 +","270-359","yes","no","no","yes","yes","yes","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V",2023-06-04,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"149","Saudi Arabia","SAU",47310,2019,"SAU","Saudi Arabia","Middle East & North Africa","High income",4,"Asia",2021-01-06,"2021-08-30",NA,2021-01-06,2021-01-06,0,29,236,NA,"equal",29,"jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Oxford/AstraZeneca, Pfizer/BioNTech",2023-04-25,"Saudi Health Council","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"150","Sudan","SDN",4090,2019,"SDN","Sudan","Sub-Saharan Africa","Low income",1,"Africa",2021-04-05,NA,NA,2021-03-09,2021-03-09,27,91,NA,NA,"who",91,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-04-02,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"151","Senegal","SEN",3480,2019,"SEN","Senegal","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-02-24,NA,NA,2021-02-23,2021-02-23,1,77,NA,NA,"who",77,"feb/2021","60-89","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing",2023-09-10,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"152","Singapore","SGP",89630,2019,"SGP","Singapore","East Asia & Pacific","High income",4,"Asia",2020-12-30,"2021-07-10","2021-08-14",2020-12-30,2020-12-30,0,22,192,227,"equal",22,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Moderna, Novavax, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac",2023-01-31,"Government of Singapore","https://data.gov.sg/dataset/covid-19-vaccination",0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,1,0,0,0,0,0,0,0,1,0,1,1
"153","Solomon Islands","SLB",2700,2019,"SLB","Solomon Islands","East Asia & Pacific","Lower middle income",1,"Oceania",2021-04-13,NA,NA,2021-03-23,2021-03-23,21,105,NA,NA,"who",105,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca",2022-10-31,"SPC Public Health Division","https://stats.pacificdata.org/vis?tm=covid&pg=0&df[ds]=SPC2&df[id]=DF_COVID_VACCINATION&df[ag]=SPC&df[vs]=1.0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"154","Sierra Leone","SLE",1700,2019,"SLE","Sierra Leone","Sub-Saharan Africa","Low income",1,"Africa",2021-03-25,"2022-12-18",NA,2021-03-15,2021-03-15,10,97,643,NA,"who",97,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","no","Oxford/AstraZeneca, Sinopharm/Beijing",2023-07-30,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"155","El Salvador","SLV",8930,2019,"SLV","El Salvador","Latin America & Caribbean","Upper middle income",2,"North America",2021-02-22,"2021-08-27",NA,2021-02-17,2021-02-17,5,71,191,NA,"who",71,"feb/2021","60-89","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac",2022-10-02,"Ministry of Health","https://covid19.gob.sv/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0
"156","San Marino","SMR",57320,2019,"SMR","San Marino","Europe & Central Asia","High income",4,"Europe",2021-02-27,"2021-05-23","2022-03-20",2021-02-24,2021-02-24,3,78,88,389,"who",78,"feb/2021","60-89","before Jun/2021","<180","yes","yes","yes","yes","yes","yes","Pfizer/BioNTech, Sputnik V",2022-05-22,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0
"157","Somalia","SOM",1180,2019,"SOM","Somalia","Sub-Saharan Africa","Low income",1,"Africa",2021-04-17,"2023-07-25",NA,2021-03-16,2021-03-16,32,98,861,NA,"who",98,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-07-25,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"158","Serbia","SRB",18360,2019,"SRB","Serbia","Europe & Central Asia","Upper middle income",3,"Europe",2021-01-08,"2021-08-12",NA,2020-12-23,2020-12-23,16,15,232,NA,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2022-06-23,"Government of Serbia","https://vakcinacija.gov.rs/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0
"159","South Sudan","SSD",1040,2015,"SSD","South Sudan","Sub-Saharan Africa","Low income",1,"Africa",2021-04-15,NA,NA,2021-04-06,2021-04-06,9,119,NA,NA,"who",119,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Oxford/AstraZeneca",2023-09-17,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"160","Sao Tome and Principe","STP",4170,2019,"STP","São Tomé and Príncipe","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-03-22,"2022-06-05",NA,2021-03-15,2021-03-15,7,97,447,NA,"who",97,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","no","Oxford/AstraZeneca",2023-07-30,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"161","Suriname","SUR",17260,2019,"SUR","Suriname","Latin America & Caribbean","Upper middle income",3,"South America",2021-03-19,NA,NA,2021-02-23,2021-02-23,24,77,NA,NA,"who",77,"feb/2021","60-89","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2022-05-23,"Government of Suriname","https://laatjevaccineren.sr/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"162","Slovak Republic","SVK",32740,2019,"SVK","Slovak Republic","Europe & Central Asia","High income",3,"Europe",2021-01-03,"2021-08-29",NA,2020-12-23,2020-12-23,11,15,249,NA,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V",2022-07-31,"Ministry of Health","https://github.com/Institut-Zdravotnych-Analyz/covid19-data/raw/main/Vaccination/OpenData_Slovakia_Vaccination_AgeGroup_District.csv",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,1,0,0,0,0,1,1,0,1
"163","Slovenia","SVN",41340,2019,"SVN","Slovenia","Europe & Central Asia","High income",4,"Europe",2020-12-27,"2021-08-04",NA,2020-12-23,2020-12-23,4,15,224,NA,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2022-07-06,"National Institute of Public Health via covid-19.sledilnik.org","https://covid-19.sledilnik.org/sl/stats",0,0,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"164","Sweden","SWE",58060,2019,"SWE","Sweden","Europe & Central Asia","High income",4,"Europe",2021-01-03,"2021-08-08","2022-01-23",2020-12-23,2020-12-23,11,15,228,396,"who",15,"before jan/2021","<30","Jun-Aug/2021","180-269","yes","yes","yes","yes","yes","yes","Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech",2023-10-08,"Public Health Agency of Sweden","https://www.fohm.se/folkhalsorapportering-statistik/statistikdatabaser-och-visualisering/vaccinationsstatistik/statistik-for-vaccination-mot-covid-19/",0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"165","Eswatini","SWZ",7970,2019,"SWZ","Eswatini","Sub-Saharan Africa","Lower middle income",2,"Africa",2021-04-05,NA,NA,2021-03-19,2021-03-19,17,101,NA,NA,"who",101,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech",2023-06-04,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"166","Sint Maarten (Dutch part)","SXM",35180,2018,"SXM","Sint Maarten (Dutch part)","Latin America & Caribbean","High income",4,"North America",2021-05-07,"2021-07-02",NA,NA,2021-05-07,NA,150,56,NA,"owid",150,"march/2021 +","90+","Jun-Aug/2021","<180","yes","yes","no","yes","yes","no","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech",2023-03-31,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"167","Seychelles","SYC",28650,2019,"SYC","Seychelles","Sub-Saharan Africa","High income",3,"Africa",2021-01-13,"2021-04-10","2021-10-25",2021-01-10,2021-01-10,3,33,90,288,"who",33,"jan/2021","30-59","before Jun/2021","<180","yes","yes","yes","yes","yes","yes","Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V",2023-04-09,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,1,0
"168","Turks and Caicos Islands","TCA",26150,2019,"TCA","Turks and Caicos Islands","Latin America & Caribbean","High income",3,"North America",2021-03-29,"2021-07-02",NA,2021-01-11,2021-01-11,77,34,172,NA,"who",34,"jan/2021","30-59","Jun-Aug/2021","<180","yes","yes","no","yes","yes","no","Pfizer/BioNTech",2023-01-06,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0
"169","Chad","TCD",1600,2019,"TCD","Chad","Sub-Saharan Africa","Low income",1,"Africa",2021-06-10,NA,NA,2021-06-04,2021-06-04,6,178,NA,NA,"who",178,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Sinopharm/Beijing",2023-08-13,"Africa Centres for Disease Control and Prevention","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0
"170","Togo","TGO",2170,2019,"TGO","Togo","Sub-Saharan Africa","Low income",1,"Africa",2021-03-24,NA,NA,2021-03-10,2021-03-10,14,92,NA,NA,"who",92,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca",2023-09-03,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"171","Thailand","THA",18070,2019,"THA","Thailand","East Asia & Pacific","Upper middle income",3,"Asia",2021-03-02,"2021-10-26","2022-03-30",2021-02-28,2021-02-28,2,82,240,395,"who",82,"feb/2021","60-89","Sep-Nov/2021","180-269","yes","yes","yes","yes","yes","yes","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac",2022-09-30,"Government of Thailand","https://ddc.moph.go.th/covid19-dashboard/",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0
"172","Tajikistan","TJK",4320,2019,"TJK","Tajikistan","Europe & Central Asia","Lower middle income",1,"Asia",2021-05-07,"2022-02-20",NA,2021-03-24,2021-03-24,44,106,333,NA,"who",106,"march/2021 +","90+","Dec/2021 +","270-359","yes","no","no","yes","yes","no","Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V",2023-06-04,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,1,0,0,1,0,0,0,0,1,1,1,0
"173","Turkmenistan","TKM",15050,2019,"TKM","Turkmenistan","Europe & Central Asia","Upper middle income",3,"Asia",2021-02-28,"2022-03-06","2023-08-06",2021-02-24,2021-02-24,4,78,375,893,"who",78,"feb/2021","60-89","Dec/2021 +","360+","yes","no","no","yes","yes","yes","EpiVacCorona, Oxford/AstraZeneca, QazVac, Sinopharm/Beijing, Sputnik V, ZF2001",2023-08-06,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,1,0,1,0,0,0,1,1,1
"174","Timor-Leste","TLS",5240,2019,"TLS","Timor-Leste","East Asia & Pacific","Lower middle income",2,"Asia",2021-04-14,"2022-01-04",NA,2021-04-07,2021-04-07,7,120,272,NA,"who",120,"march/2021 +","90+","Dec/2021 +","270-359","yes","no","no","yes","yes","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac",2023-06-26,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0
"175","Tonga","TON",7150,2019,"TON","Tonga","East Asia & Pacific","Upper middle income",2,"Oceania",2021-04-20,"2021-11-22","2022-07-25",2021-04-14,2021-04-14,6,127,222,467,"who",127,"march/2021 +","90+","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","yes","Oxford/AstraZeneca",2023-04-11,"SPC Public Health Division","https://stats.pacificdata.org/vis?tm=covid&pg=0&df[ds]=SPC2&df[id]=DF_COVID_VACCINATION&df[ag]=SPC&df[vs]=1.0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"176","Trinidad and Tobago","TTO",25700,2019,"TTO","Trinidad and Tobago","Latin America & Caribbean","High income",3,"North America",2021-02-22,"2021-11-06",NA,2021-02-17,2021-02-17,5,71,262,NA,"who",71,"feb/2021","60-89","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing",2022-09-21,"Ministry of Health","https://services3.arcgis.com/x3I4DqUw3b3MfTwQ/arcgis/rest/services/service_7a519502598f492a9094fd0ad503cf80/FeatureServer/0/query",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"177","Tunisia","TUN",11250,2019,"TUN","Tunisia","Middle East & North Africa","Lower middle income",2,"Africa",2021-03-13,"2021-11-22",NA,2021-03-13,2021-03-13,0,95,254,NA,"equal",95,"march/2021 +","90+","Sep-Nov/2021","180-269","yes","yes","no","yes","yes","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-06-20,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"178","Turkiye","TUR",27240,2019,"TUR","Türkiye","Europe & Central Asia","Upper middle income",3,"Asia",2021-01-14,"2021-08-19",NA,NA,2021-01-14,NA,37,217,NA,"owid",37,"jan/2021","30-59","Jun-Aug/2021","180-269","yes","yes","no","yes","yes","no","Pfizer/BioNTech, Sinovac, Turkovac",2022-11-22,"COVID-19 Vaccine Information Platform","https://covid19asi.saglik.gov.tr/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,1,0,1,0
"179","Tuvalu","TUV",6690,2019,"TUV","Tuvalu","East Asia & Pacific","Upper middle income",2,"Oceania",2021-04-27,"2021-09-10","2022-07-21",2021-04-13,2021-04-13,14,126,150,464,"who",126,"march/2021 +","90+","Sep-Nov/2021","<180","yes","yes","no","yes","yes","yes","Oxford/AstraZeneca",2023-02-01,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"180","Tanzania","TZA",2720,2019,"TZA","Tanzania","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-08-08,"2022-11-27",NA,2021-07-28,2021-07-28,11,232,487,NA,"who",232,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","no","Johnson&Johnson, Pfizer/BioNTech, Sinopharm/Beijing",2023-03-12,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0
"181","Uganda","UGA",2120,2019,"UGA","Uganda","Sub-Saharan Africa","Low income",1,"Africa",2021-03-15,NA,NA,2021-03-10,2021-03-10,5,92,NA,NA,"who",92,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac",2023-05-28,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0
"182","Ukraine","UKR",13510,2019,"UKR","Ukraine","Europe & Central Asia","Lower middle income",2,"Europe",2021-02-26,NA,NA,2021-02-24,2021-02-24,2,78,NA,NA,"who",78,"feb/2021","60-89","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac",2022-02-27,"Ministry of Health","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0
"183","Uruguay","URY",23070,2019,"URY","Uruguay","Latin America & Caribbean","High income",3,"South America",2021-02-27,"2021-06-18","2021-08-12",2021-02-27,2021-02-27,0,81,111,166,"equal",81,"feb/2021","60-89","Jun-Aug/2021","<180","yes","yes","yes","yes","yes","yes","Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac",2023-10-18,"Ministry of Health via vacuna.uy","https://monitor.uruguaysevacuna.gub.uy/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0
"184","United States","USA",66120,2019,"USA","United States","North America","High income",4,"North America",2020-12-13,"2021-05-14",NA,2020-12-14,2020-12-13,-1,5,152,NA,"owid",5,"before jan/2021","<30","before Jun/2021","<180","yes","yes","no","yes","yes","no","Johnson&Johnson, Moderna, Novavax, Pfizer/BioNTech",2023-05-09,"Centers for Disease Control and Prevention","https://data.cdc.gov/Vaccinations/COVID-19-Vaccination-Trends-in-the-United-States-N/rh2h-3yt2",0,0,0,0,0,0,0,0,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1
"185","Uzbekistan","UZB",7750,2019,"UZB","Uzbekistan","Europe & Central Asia","Lower middle income",2,"Asia",2021-04-06,"2022-03-13",NA,2021-04-28,2021-04-06,-22,119,341,NA,"owid",119,"march/2021 +","90+","Dec/2021 +","270-359","yes","no","no","yes","yes","no","Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik Light, Sputnik V, ZF2001",2023-08-13,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,1,0,0,1,0,1,0,0,1,1,1,1
"186","St. Vincent and the Grenadines","VCT",14670,2019,"VCT","St. Vincent and the Grenadines","Latin America & Caribbean","Upper middle income",3,"North America",2021-03-17,NA,NA,2021-02-01,2021-02-01,44,55,NA,NA,"who",55,"feb/2021","30-59","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik Light, Sputnik V",2023-04-21,"World Health Organization","https://covid19.who.int/",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0
"187","Venezuela, RB","VEN",16960,2011,"VEN","Venezuela, RB","Latin America & Caribbean",NA,3,"South America",2021-03-04,"2021-12-17",NA,2021-02-22,2021-02-22,10,76,298,NA,"who",76,"feb/2021","60-89","Dec/2021 +","270-359","yes","yes","no","yes","yes","no","Abdala, Sinopharm/Beijing, Sinovac, Soberana02, Sputnik Light, Sputnik V",2022-12-07,"Pan American Health Organization","https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,1,1,1
"188","Vietnam","VNM",10150,2019,"VNM","Vietnam","East Asia & Pacific","Lower middle income",2,"Asia",2021-03-12,"2021-12-02","2022-01-13",2021-03-08,2021-03-08,4,90,269,311,"who",90,"march/2021 +","90+","Dec/2021 +","180-269","yes","yes","yes","yes","yes","yes","Abdala, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V",2023-06-30,"World Health Organization","https://covid19.who.int/",1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,1,0,0,0,0,1,1,1,1
"189","Vanuatu","VUT",3470,2019,"VUT","Vanuatu","East Asia & Pacific","Lower middle income",1,"Oceania",2021-06-03,"2022-10-17",NA,2021-06-02,2021-06-02,1,176,502,NA,"who",176,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","no","Oxford/AstraZeneca",2023-02-20,"SPC Public Health Division","https://stats.pacificdata.org/vis?tm=covid&pg=0&df[ds]=SPC2&df[id]=DF_COVID_VACCINATION&df[ag]=SPC&df[vs]=1.0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"190","Samoa","WSM",6350,2019,"WSM","Samoa","East Asia & Pacific","Lower middle income",2,"Oceania",2021-05-04,"2021-11-30","2022-05-02",2021-04-18,2021-04-18,16,131,226,379,"who",131,"march/2021 +","90+","Sep-Nov/2021","180-269","yes","yes","yes","yes","yes","yes","Oxford/AstraZeneca",2023-04-17,"SPC Public Health Division","https://stats.pacificdata.org/vis?tm=covid&pg=0&df[ds]=SPC2&df[id]=DF_COVID_VACCINATION&df[ag]=SPC&df[vs]=1.0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
"191","Kosovo","XKX",12060,2019,NA,"Kosovo","Europe & Central Asia","Upper middle income",2,NA,NA,NA,NA,2021-03-31,2021-03-31,NA,113,NA,NA,"who",113,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"192","Yemen, Rep.","YEM",3280,2013,"YEM","Yemen, Rep.","Middle East & North Africa","Low income",1,"Asia",2021-05-09,NA,NA,2021-04-20,2021-04-20,19,133,NA,NA,"who",133,"march/2021 +","90+","not reached","not reached","yes","no","no","yes","no","no","CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V",2023-09-17,"World Health Organization","https://covid19.who.int/",0,1,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,1,0,0,1,0,0,0,0,1,1,1,0
"193","South Africa","ZAF",14080,2019,"ZAF","South Africa","Sub-Saharan Africa","Upper middle income",2,"Africa",2021-02-19,NA,NA,2021-02-17,2021-02-17,2,71,NA,NA,"who",71,"feb/2021","60-89","not reached","not reached","yes","no","no","yes","no","no","Johnson&Johnson, Pfizer/BioNTech",2023-06-04,"Ministry of Health","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0
"194","Zambia","ZMB",3450,2019,"ZMB","Zambia","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-04-18,"2022-10-27",NA,2021-04-14,2021-04-14,4,127,561,NA,"who",127,"march/2021 +","90+","Dec/2021 +","360+","yes","no","no","yes","yes","no","Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing",2023-06-25,"Government of Zambia","https://covid19.who.int/",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0
"195","Zimbabwe","ZWE",2260,2019,"ZWE","Zimbabwe","Sub-Saharan Africa","Lower middle income",1,"Africa",2021-02-21,NA,NA,2021-02-18,2021-02-18,3,72,NA,NA,"who",72,"feb/2021","60-89","not reached","not reached","yes","no","no","yes","no","no","Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V",2022-10-09,"Ministry of Health","https://www.arcgis.com/home/webmap/viewer.html?url=https://services9.arcgis.com/DnERH4rcjw7NU6lv/ArcGIS/rest/services/Vaccine_Distribution_Program/FeatureServer&source=sd",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,1,0,0,0,0,0,1,1,0
